The LifeMD (LFMD)-Medifast (MED) partnership provides LifeMD patients access to Medifast’s Optavia medically-supported weight loss program. Dan Chard, Medifast CEO and Justin Schreiber, LifeMD CEO discuss this partnership and medically-supported weight loss. This partnership is supported by Medifast’s $20M investment into LifeMD, including a $10M payment and $10M direct equity investment. It gives patients the personalized 1-on-1 care they need while offering scalability needed to meet growing demand. They then go over what investors should know about medically-supported weight loss. Tune in to find out more about the stock market today.